Unearthing the Evidence: Post-Mortem Interrogation of Cardiac Implantable Electronic Devices

2021 ◽  
Vol 30 ◽  
pp. S104
Author(s):  
T. Block ◽  
E. Paratz ◽  
A. La Gerche ◽  
D. Stub ◽  
N. Strathmore ◽  
...  
2021 ◽  
Vol 42 (Supplement_1) ◽  
Author(s):  
T Block ◽  
E Paratz ◽  
A La Gerche ◽  
D Stub ◽  
N Strathmore ◽  
...  

Abstract Background The diagnostic yield of post-mortem interrogation of cardiac implantable electronic devices (CIEDs) including pacemakers, defibrillators and implantable loop recorders has not been well described. Methods We reviewed all post-mortem CIED interrogations performed by our statewide Institute of Forensic Medicine between 2005–2020 for investigation of sudden or unexplained death. Results 260 patients (68.8% male, median age 72.8 years [IQR 62.7–82.2]) underwent post-mortem CIED interrogation (202 pacemakers, 56 defibrillators and 2 loop recorders). CIEDs were implanted for a median of 2.0 [IQR 0.75–5] years, with 19 devices requiring replacement (and 5 end of life). Post-mortem interrogation was successful in 256 (98.5%) cases. Potential CIED malfunction was identified in 21 (8.1%) cases: untreated ventricular arrhythmias (n=13), lead failures (n=3) and battery depletion (n=5). CIED interrogation directly informed cause of death in 130 (50.0%) cases, with fatal ventricular arrhythmias identified in 121 patients (46.5%). In retrospect, 72 (27.7%) patients had abnormalities recorded by their device in the 30 days preceding death: non-sustained ventricular tachycardia (n=26), rapid atrial fibrillation (n=17), longevity concerns (n=22), intrathoracic impedance alarms (n=3), lead issues (n=3) or therapy delivered (n=1). In 6 cases where the patient was found deceased after a prolonged time, CIED interrogation accurately determined time of death. In one case, CIED interrogation was the primary method of patient identification. Conclusion Post-mortem CIED interrogation frequently contributes important information regarding critical device malfunction, pre-mortem abnormalities, cause and time of death or patient identity. Device interrogation should be considered for select patients with CIEDs undergoing autopsy. FUNDunding Acknowledgement Type of funding sources: None.


2011 ◽  
Vol 3 (1) ◽  
pp. 74
Author(s):  
Kathy L Lee ◽  

Cardiac pacemakers have been the standard therapy for patients with bradyarrhythmias for several decades. The pacing lead is an integral part of the system, serving as a conduit for the delivery of energy pulses to stimulate the myocardium. However, it is also the Achilles’ heel of pacemakers, being the direct cause of most device complications both acutely during implant and chronically years afterwards. Leadless pacing with ultrasound-mediated energy has been demonstrated in animals and humans to be safe and feasible in acute studies. Implantable defibrillators revolutionised the treatment and prevention of sudden cardiac death. Subcutaneous implantable defibrillators have been under development for more than 10 years. A permanent implantable system has been shown to be feasible in treating induced and spontaneous ventricular tachyarrhythmias. These developments and recent advances in pacing and defibrillation will arouse further interest in the research and development of leadless cardiac implantable electronic devices.


Author(s):  
Khurrum Khan ◽  
Jitae A. Kim ◽  
Andra Gurgu ◽  
Muzamil Khawaja ◽  
Dragos Cozma ◽  
...  

EP Europace ◽  
2014 ◽  
Vol 17 (3) ◽  
pp. 364-369 ◽  
Author(s):  
J. Benezet-Mazuecos ◽  
J. M. Rubio ◽  
M. Cortes ◽  
J. A. Iglesias ◽  
S. Calle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document